ZBP1 , an M1 Macrophage‐Associated Biomarker Identified by Machine Learning, Suppresses Tumorigenesis and Predicts Immunotherapy Response in Head and Neck Squamous Cell Carcinoma
Journal of Cellular and Molecular Medicine · 2025
DOI: 10.1111/jcmm.70953 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cellular and Molecular Medicine, 2025. Verfasst von Feng Gao und 4 weiteren Autor:innen. Beteiligte Einrichtung: School of Dentistry, Institute of Stomatological Research, Medical School, Shenzhen University, Shenzhen, China. Hauptthemen laut MEDLINE: Squamous Cell Carcinoma of Head and Neck, Biomarkers, Tumor, Macrophages, Machine Learning. Die Arbeit nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Shenzhen Science and Technology Innovation Commission stable support project.
Abstract (Originalsprache)
Head and neck squamous cell carcinoma (HNSCC) is a highly aggressive cancer with restricted therapeutic options and unfavourable survival outcomes. To identify novel prognostic biomarkers and therapeutic targets, we investigated the role of macrophage polarisation in HNSCC progression. Using integrative computational approaches, including biological network algorithms and molecular subtyping, we established a robust gene signature associated with M1/M2 macrophage balance, which exhibited significant prognostic value in HNSCC patients. Further analysis employing multi‐model machine learning algorithms pinpointed ZBP1 as the pivotal gene, linking it to key clinical and immunological features, including disease progression, immune microenvironment remodelling, tumour mutational burden, and response to immune checkpoint inhibitors. Mechanistic studies confirmed ZBP1's tumour‐suppressive function, demonstrating its ability to inhibit HNSCC cell proliferation and migration in vitro. Moreover, macrophage co‐culture assays revealed that ZBP1 modulates immune regulation by restricting macrophage recruitment and altering polarisation dynamics. Collectively, our findings highlight ZBP1 as a promising prognostic biomarker and a potential immunotherapeutic target in HNSCC. This study not only enhances our understanding of macrophage‐mediated tumour immunity but also provides mechanistic insights into how ZBP1 integrates tumour‐intrinsic and immune‐regulatory pathways to influence HNSCC progression. These discoveries may contribute to the development of more precise therapeutic strategies for this aggressive malignancy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Dentistry, Institute of Stomatological Research, Medical School, Shenzhen University, Shenzhen, China.
- Medical School, Shenzhen University, Shenzhen, China.
- Cancer Centre, Faculty of Health Sciences, University of Macau, Macau, China.
ORCID-Profile: Feng Gao, Kaifang Wang, Ou Sha
Förderung
- Shenzhen Science and Technology Innovation Commission stable support project
Zitieren
APA
Gao, F., Wang, S., Fang, T., Wang, K., & Sha, O. (2025). ZBP1 , an M1 Macrophage‐Associated Biomarker Identified by Machine Learning, Suppresses Tumorigenesis and Predicts Immunotherapy Response in Head and Neck Squamous Cell Carcinoma. Journal of Cellular and Molecular Medicine. https://doi.org/10.1111/jcmm.70953
Vancouver
Gao F, Wang S, Fang T, Wang K, Sha O. ZBP1 , an M1 Macrophage‐Associated Biomarker Identified by Machine Learning, Suppresses Tumorigenesis and Predicts Immunotherapy Response in Head and Neck Squamous Cell Carcinoma. Journal of Cellular and Molecular Medicine. 2025. doi:10.1111/jcmm.70953
BibTeX
@article{Gao2025,
author = {Gao, Feng and Wang, Suya and Fang, Tong and Wang, Kaifang and Sha, Ou},
title = {ZBP1 , an M1 Macrophage‐Associated Biomarker Identified by Machine Learning, Suppresses Tumorigenesis and Predicts Immunotherapy Response in Head and Neck Squamous Cell Carcinoma},
journal = {Journal of Cellular and Molecular Medicine},
year = {2025},
doi = {10.1111/jcmm.70953}
}
EUVIMED